# Alfuzosin Hydrochloride extended release

NDC: 69097-844
Generic name: Alfuzosin Hydrochloride
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160630

FDA application: ANDA090284

## Active ingredients

- ALFUZOSIN HYDROCHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-844"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-844
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cc028d5-309f-4ce3-a2d7-5804ab57677d